3May 2017

N4 Pharma Plc (AIM:N4P) Admission to AIM/Interview with CEO

N4 Pharma Plc (AIM: N4P), a specialist pharmaceutical company which reformulates existing drugs and vaccines to improve their performance, is pleased to announce the readmission today of the Company’s ordinary shares to trading on AIM and the commencement of dealings in the New Ordinary Shares under the ticker N4P (“Admission”).

Share Talk took the opportunity to speak with N4 Pharma’s Founder and CEO Nigel Theobald following their admission and first day of shares being available for dealing on AIM .